eISSN: 2081-2841
ISSN: 1689-832X
Journal of Contemporary Brachytherapy
Current Issue Archive Supplements Articles in Press Journal Information Aims and Scope Editorial Office Editorial Board Register as Author Register as Reviewer Instructions for Authors Abstracting and indexing Subscription Advertising Information Links
SCImago Journal & Country Rank

Interview with Professor Janusz Skowronek
ABS 2015
5/2018
vol. 10
 
Share:
Share:
more
 
 
abstract:
Review paper

A systematic review of treating recurrent head and neck cancer: a reintroduction of brachytherapy with or without surgery

Julianna Rodin, Voichita Bar-Ad, David Cognetti, Joseph Curry, Jennifer Johnson, Chad Zender, Laura Doyle, David Kutler, Benjamin Leiby, William Keane, Adam Luginbuhl

J Contemp Brachytherapy 2018; 10, 5: 454–462
Online publish date: 2018/10/31
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Purpose
To review brachytherapy use in recurrent head and neck carcinoma (RHNC) with focus on its efficacy and complication rates.

Material and methods
A literature search of PubMed, Ovid, Google Scholar, and Scopus was conducted from 1990 to 2017. Publications describing treatment of RHNC with brachytherapy with or without surgery were included. The focus of this review is on oncologic outcomes and the safety of brachytherapy in the recurrent setting.

Results
Thirty studies involving RHNC treatment with brachytherapy were reviewed. Brachytherapy as adjunctive treatment to surgical resection appears to be associated with an improved local regional control and overall survival, when compared with the published rates for re-irradiation utilizing external beam radiotherapy (RT) or brachytherapy alone. Safety data remains variable with different isotopes and dose rates with implantable brachytherapy demonstrating a tolerable side effect profile.

Conclusions
Although surgery remains a mainstay treatment for RHNC, intraoperative interstitial brachytherapy delivery as adjunctive therapy may improve the treatment outcome and may be associated with fewer complication rates as compared to reirradiation using external beam radiotherapy. Further investigations are required to elucidate the role of brachytherapy for RHNC.

keywords:

cesium, head and neck cancer, recurrent

references:
Siegel R, Miller K, Jemal A. Cancer statistics. CA Cancer J Clin 2016; 66: 7-30.
Siegel R, Miller K, Jemal A. Cancer statistics. CA Cancer J Clin 2017; 67: 7-30.
Siegel R, Miller K, Jemal A. Cancer statistics. CA Cancer J Clin 2015; 65: 5-29.
Vokes E, Weichselbaum R, Lippman S, Hong WK. Head and neck cancer. N Engl J Med 1993; 328: 184-194.
Grimard L, Esche B, Lamothe A et al. Interstitial low-dose-rate brachytherapy in the treatment of recurrent head and neck malignancies. Head Neck 2006; 28: 888-895.
Henderson P, Kutler D, Parashar B et al. Neither high-dose nor low-dose brachytherapy increases flap morbidity in salvage treatment of recurrent head and neck cancer. J Contemp Brachytherapy 2016; 8: 308-312.
Quon H, Harrison LB. Brachytherapy in the treatment of head and neck cancer. Oncology (Williston Park) 2002; 16: 1379-1396.
Strnad V, Lotter M, Kreppner S, Fietkau R. Reirradiation for recurrent head and neck cancer with salvage interstitial pulsed-dose-rate brachytherapy: Long-term results. Strahlenther Onkol 2015; 191: 495-500.
Narayana A, Cohen G, Zaider M et al. High-dose-rate interstitial brachytherapy in recurrent and previously irradiated head and neck cancers-preliminary results. Brachytherapy 2007; 6: 157-163.
Martinez-Fernandez M, Alcalde J, Cambeiro M et al. Perioperative high dose rate brachytherapy (PHDRB) in previously irradiated head and neck cancer: Results of a phase I/II reirradiation study. Radiother Oncol 2017; 122: 255-259.
Schiefke F, Hildebrandt G, Pohlmann S et al. Combination of surgical resection and HDR-brachytherapy in patients with recurrent or advanced head and neck carcinomas. J Craniomaxillofac Surg 2008; 36: 285-292.
Strnad V, Lotter M, Kreppner S, Fietkau R. Re-irradiation with interstitial pulsed-dose-rate brachytherapy for unresectable recurrent head and neck carcinoma. Brachytherapy 2014; 13: 187-195.
Scala L, Hu K, Urken M et al. Intraoperative high-dose-rate radiotherapy in the management of locoregionally recurrent head and neck cancer. Head Neck 2013; 35: 485-492.
Teudt I, Kovacs G, Ritter M et al. Intensity modulated perioperative HDR brachytherapy for recurrent and/or advanced head and neck metastases. Eur Arch Otorhinolaryngol 2016; 273: 2707-2715.
Kasperts N, Slotman B, Leemans C et al. A review on re-irradiation for recurrent and second primary head and neck cancer. Oral Oncol 2005; 41: 225-243.
Patel P, Salama J. Reirradiation for recurrent head and neck cancer. Expert Rev Anticancer Ther 2012; 12: 1177-1189.
Puthawala A, Nisar Syed A, Gamie S et al. Interstitial low-dose-rate brachytherapy as a salvage treatment for recurrent head-and-neck cancers: long-term results. Int J Radiat Oncol Biol Phys 2001; 51: 354-362.
Hepel J, Nisar Syed A, Puthawala A et al. Salvage high-dose-rate (HDR) brachytherapy for recurrent head-and-neck cancer. Int J Radiat Oncol Biol Phys 2005; 62: 1444-1450.
Jiang P, Jiang Y, Wang J et al. Percutaneous ultrasonography-guided permanent iodine-125 implantation as salvage therapy for recurrent head and neck carcinomas. Cancer Biother Radiopharm 2011; 26: 753-757.
Rudzianskas V, Inciura A, Juozaityte E et al. Reirradiation of recurrent head and neck cancer using high-dose-rate brachytherapy. Acta Otorhinolaryngol Ital 2012; 32: 297-303.
Park R, Liberman F, Lee DJ et al. Iodine-125 seed implantation as an adjunct to surgery in advanced recurrent squamous cell cancer of the head and neck. Laryngoscope 1991; 101: 405-410.
Pellizzon A, dos Santos Novaes P, Conte Maia M et al. Interstitial high-dose-rate brachytherapy combined with cervical dissection on head and neck cancer. Head Neck 2005; 27: 1035-1041.
Pham A, Arora S, Wernicke G et al. Cesium-131 brachytherapy in high risk and recurrent head and neck cancers: first report of long-term outcomes. J Contemp Brachytherapy 2015; 7: 445-452.
Kupferman M, Morrison W, Santillan A et al. The role of interstitial brachytherapy with salvage surgery for the management of recurrent head and neck cancers. Cancer 2007; 109: 2052-2057.
Wong S, Machtay M, Li Y. Locally recurrent, previously irradiated head and neck cancer: concurrent re-irradiation and chemotherapy, or chemotherapy alone? J Clin Oncol 2006; 24: 2653-2658.
Bartochowska A, Skowronek J, Wierzbicka M et al. Is there a place for brachytherapy in the salvage treatment of cervical lymph node metastases of head and neck cancers? Brachytherapy 2015; 14: 933-938.
Huang H, Xu S, Li F et al. Clinical application of computed tomography-guided 125I seed interstitial implantation for head and neck cancer patients with unmanageable cervical lymph node metastases. Eur J Med Res 2016; 21: 18.
Tselis N, Ratka M, Vogt HG et al. Hypofractionated accelerated CT-guided interstitial 192Ir-HDR-brachytherapy as re-irradiation in inoperable recurrent cervical lymphadenopathy from head and neck cancer. Radiother Oncol 2011; 98: 57-62.
Nutting C, Horlock N, A’Hern R et al. Manually after-loaded 192Ir low-dose rate brachytherapy after subtotal excision and flap reconstruction of recurrent cervical lymphadenopathy from head and neck cancer. Radiother Oncol 2006; 80: 39-42.
Cox J, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995; 31: 1341-1346.
Parasher B, Wernicke A, Pavese A et al. Cesium-131 permanent brachytherapy: dosimetric evaluation and radiation exposure to surgeons, radiation oncologists, and staff. Brachytherapy 2011; 10: 508-513.
Zhu L, Jiang Y, Wang J et al. An investigation of 125I seed permanent implantation for recurrent carcinoma in the head and neck after surgery and external beam radiotherapy. World J Surg Oncol 2013; 11: 60.
Yondorf M, Schwartz T, Boockvar J et al. Radiation exposure and safety precautions following 131Cs brachytherapy in patients with brain tumors. Health Phys 2017; 112: 403-408.
Goodwin WJ Jr. Salvage surgery for patients with recurrent squamous cell carcinoma of the upper aerodigestive tract: when do the ends justify the means? Laryngoscope 2000; 110: 1-18.
Strojan P, Corry J, Eisbruch A et al. Recurrent and second primary squamous cell carcinoma of the head and neck: when and how to irradiate. Head Neck 2015; 37: 134-150.
Lee N, Chan K, Bekelman J et al. Salvage re-irradiation for recurrent head and neck cancer. Int J Radiat Oncol Biol Phys 2007; 68: 731-740.
Glatzel M, Buntzel J, Schroder D et al. High-dose-rate brachytherapy in the treatment of recurrent and residual head and neck cancer. Laryngoscope 2002; 112: 1366-1371.
Meng N, Liang Jiang Y, Jie Wang J et al. Permanent implantation of iodine-125 seeds as a salvage therapy for recurrent head and neck carcinoma after radiotherapy. Cancer Invest 2012; 30: 236-242.
Wiegand S, Sesterhenn AM, Zimmermann AP et al. Interstitial HDR brachytherapy for advanced recurrent squamous cell carcinoma of the head and neck. Anticancer Res 2013; 33: 249-252.
Cornes P, Cox H, Rhys-Evans P et al. Salvage treatment for inoperable neck nodes in head and neck cancer using combined iridium-192 brachytherapy and surgical reconstruction. Br J Surg 1996; 83: 1620-1622.
Teckie S, Scala L, Ho F et al. High-dose-rate intraoperative brachytherapy and radical surgical resection in the management of recurrent head-and-neck cancer. Brachytherapy 2013; 12: 228-234.
Perry D, Chan K, Wolden S et al. High-dose-rate intraoperative radiation therapy for recurrent head-and-neck cancer. Int J Radiat Oncol Biol Phys 2010; 76: 1140-1146.
Kolotas C, Tselis N, Sommerlad M et al. Reirradiation for recurrent neck metastases of head-and-neck tumors using CT-guided interstitial 192Ir HDR brachytherapy. Strahlenther Onkol 2007; 183: 69-75.
Bollet M, Lapeyre M, Marchal C et al. Cervical lymph node relapses of head-and-neck squamous cell carcinoma: is brachytherapy a therapeutic option? Int J Radiat Oncol Biol Phys 2001; 51: 1305-1312.
Sulman E, Schwartz D, Le T et al. IMRT reirradiation of head and neck cancer-disease control and morbidity outcomes. Int J Radiat Oncol Biol Phys 2009; 73: 399-409.
Janot F, de Raucourt D, Benhamou E et al. Randomized trial of postoperative reirradiation combined with chemotherapy after salvage surgery compared with salvage surgery alone in head and neck carcinoma. J Clin Oncol 2008; 26: 5518-5523.
Takiar V, Garden A, Ma D et al. Reirradiation of head and neck cancers with intensity modulated radiation therapy: outcomes and analyses. Int J Radiat Oncol Biol Phys 2016; 95: 1117-1131.
Vermorken JB, Specenier P. Optimal treatment for recurrent/metastatic head and neck cancer. Ann Oncol 2010; 21: 252-261.
Jeong S, Yoo EJ, Kim JY et al. Re-irradiation of unresectable recurrent head and neck cancer: Helical tomotherapy as image-guided intensity-modulated radiotherapy. Rad Oncol J 2013; 31: 206-215.
Vargo J, Kubicek G, Ferris R et al. Adjuvant stereotactic body radiotherapy + cetuximab following salvage surgery in previously irradiated head and neck cancer. Laryngoscope 2014; 124: 1579-1584.
 
Quick links
© 2018 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe